Clover Health Investments Statistics
Total Valuation
CLOV has a market cap or net worth of $605.65 million. The enterprise value is $267.64 million.
| Market Cap | 605.65M |
| Enterprise Value | 267.64M |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CLOV has 496.44 million shares outstanding. The number of shares has increased by 0.15% in one year.
| Shares Outstanding | 496.44M |
| Shares Change (YoY) | +0.15% |
| Shares Change (QoQ) | +16.77% |
| Owned by Insiders (%) | 9.29% |
| Owned by Institutions (%) | 22.61% |
| Float | 375.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.33 |
| Forward PS | 0.44 |
| PB Ratio | 2.07 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.55, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.55 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -22,845.43 |
Financial Efficiency
Return on equity (ROE) is -52.00% and return on invested capital (ROIC) is -53.45%.
| Return on Equity (ROE) | -52.00% |
| Return on Assets (ROA) | -18.00% |
| Return on Capital (ROIC) | -53.45% |
| Revenue Per Employee | $3.36M |
| Profits Per Employee | -$289,719 |
| Employee Count | 552 |
| Asset Turnover | 2.08 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +39.65% in the last 52 weeks. The beta is 2.10, so CLOV's price volatility has been higher than the market average.
| Beta (5Y) | 2.10 |
| 52-Week Price Change | +39.65% |
| 50-Day Moving Average | 0.97 |
| 200-Day Moving Average | 0.94 |
| Relative Strength Index (RSI) | 58.19 |
| Average Volume (20 Days) | 5,261,682 |
Short Selling Information
The latest short interest is 35.32 million, so 7.11% of the outstanding shares have been sold short.
| Short Interest | 35.32M |
| Short Previous Month | 38.08M |
| Short % of Shares Out | 7.11% |
| Short % of Float | 9.41% |
| Short Ratio (days to cover) | 5.24 |
Income Statement
In the last 12 months, CLOV had revenue of $1.85 billion and -$159.93 million in losses. Loss per share was -$0.34.
| Revenue | 1.85B |
| Gross Profit | 289.24M |
| Operating Income | -158.64M |
| Pretax Income | -159.93M |
| Net Income | -159.93M |
| EBITDA | -157.37M |
| EBIT | -159.92M |
| Loss Per Share | -$0.34 |
Balance Sheet
The company has $342.35 million in cash and $4.34 million in debt, giving a net cash position of $338.01 million or $0.68 per share.
| Cash & Cash Equivalents | 342.35M |
| Total Debt | 4.34M |
| Net Cash | 338.01M |
| Net Cash Per Share | $0.68 |
| Equity (Book Value) | 292.47M |
| Book Value Per Share | 0.59 |
| Working Capital | 196.35M |
Cash Flow
In the last 12 months, operating cash flow was -$168.97 million and capital expenditures -$778,000, giving a free cash flow of -$169.75 million.
| Operating Cash Flow | -168.97M |
| Capital Expenditures | -778,000 |
| Free Cash Flow | -169.75M |
| FCF Per Share | -$0.35 |
Margins
Gross margin is 15.61%, with operating and profit margins of -8.56% and -8.63%.
| Gross Margin | 15.61% |
| Operating Margin | -8.56% |
| Pretax Margin | -8.63% |
| Profit Margin | -8.63% |
| EBITDA Margin | -8.49% |
| EBIT Margin | -8.63% |
| FCF Margin | -9.16% |
Dividends & Yields
CLOV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.15% |
| Shareholder Yield | -0.15% |
| Earnings Yield | -26.41% |
| FCF Yield | -28.03% |
Analyst Forecast
The average price target for CLOV is $1.50, which is 22.95% higher than the current price. The consensus rating is "Hold".
| Price Target | $1.50 |
| Price Target Difference | 22.95% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | -2.34% |
| EPS Growth Forecast (5Y) | -16.04% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CLOV has an Altman Z-Score of -1.26 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.26 |
| Piotroski F-Score | 4 |